Cordlife shares jump 18% after renewal of restricted licence
I'm PortAI, I can summarize articles.
Cordlife shares rose over 18% on January 14 after the Health Ministry renewed its restricted licence for another year, allowing the company to continue storing cord blood. The shares increased from 12.7 cents to 15 cents following the announcement. Cordlife is also facing claims totaling at least $5.45 million from parents regarding damaged cord blood units, which could negatively impact its financial position if ordered to pay this financial year.
Source: Straitstimes The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments